Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Encephalopathy associated with sulindac.

M Y Neufeld, A D Korczyn

    Human Toxicology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Sulindac, a non-steroidal anti-inflammatory drug, can cause encephalopathy. This case report highlights a rare adverse effect of sulindac (Clinoril) in patients.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pseudo-anticipation in Creutzfeldt-Jakob disease is due to a rhomboid-shaped artifact.

    European journal of neurology·2019
    Same author

    Clinical and radiological determinants of transient symptoms associated with infarction (TSI).

    Journal of the neurological sciences·2018
    Same author

    High hair cortisol concentrations predict worse cognitive outcome after stroke: Results from the TABASCO prospective cohort study.

    Psychoneuroendocrinology·2017
    Same author

    Gait instability in valproate-treated patients: Call to measure ammonia levels.

    Acta neurologica Scandinavica·2017
    Same author

    Quality-of-life perception by Parkinson's disease patients and caregivers.

    Acta neurologica Scandinavica·2017
    Same author

    The effect of schooling on reported age of onset of cognitive decline: A collaborative study.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2016
    Same journal

    Intracellular localization of cerium. A microanalytical study using an electron microprobe and ionic microanalysis.

    Human toxicology·1989
    Same journal

    Self-poisoning in Sri Lanka: factors determining the choice of the poisoning agents.

    Human toxicology·1989
    Same journal

    The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone).

    Human toxicology·1989
    Same journal

    Pharmacokinetics and toxic effects of diltiazem in massive overdose.

    Human toxicology·1989
    Same journal

    Acute renal failure following accidental cutaneous absorption of phenol: application of NMR urinalysis to monitor the disease process.

    Human toxicology·1989
    Same journal

    Toxicological data after heroin overdose.

    Human toxicology·1989
    See all related articles

    Area of Science:

    • Pharmacology
    • Neurology
    • Internal Medicine

    Background:

    • Sulindac is a non-steroidal anti-inflammatory drug (NSAID) belonging to the indene derivative class.
    • Its therapeutic efficacy is comparable to that of indomethacin for managing inflammatory conditions.

    Observation:

    • This report details a specific case of a patient experiencing adverse effects following sulindac administration.
    • The observed adverse event was encephalopathy, a serious neurological complication.

    Findings:

    • A direct association was identified between sulindac intake and the development of encephalopathy.
    • This suggests a potential neurotoxic effect of sulindac in susceptible individuals.

    Implications:

  • Clinicians should be aware of the potential for sulindac-induced encephalopathy.
  • Further investigation into the mechanisms of NSAID-induced neurotoxicity may be warranted.